Works matching IS 1933088X AND DT 2017 AND VI 15 AND IP 4

Results: 7

PH Grand Rounds: When Pulmonary Arterial Hypertension Is Complicated by Pericardial Disease.

Published in:

Advances in Pulmonary Hypertension, 2017, v. 15, n. 4, p. 198, doi. 10.21693/1933-088X-15.4.198

By:

Levine, Deborah J.;
Smith, Avery;
Mora, Adan;
Fenstad, Eric

Publication type:

Article

Whatever Happened to Oral Monotherapy?

Published in:

Advances in Pulmonary Hypertension, 2017, v. 15, n. 4, p. 190, doi. 10.21693/1933-088X-15.4.190

By:

Lee, John J.;
Llanos, Alexander;
Channick, Richard

Publication type:

Article

Guest Editor's Memo.

Published in:

Advances in Pulmonary Hypertension, 2017, v. 15, n. 4, p. 178, doi. 10.21693/1933-088X-15.4.178b

By:

Burger, Charles D.;
Schilz, Robert

Publication type:

Article

Editor's Memo.

Published in:

Advances in Pulmonary Hypertension, 2017, v. 15, n. 4, p. 178, doi. 10.21693/1933-088X-15.4.178a

By:

Burger, Charles D.

Publication type:

Article

Ask The Expert: What Are Some Pitfalls and Promises of the Current PAH Treatment Guidelines?

Published in:

Advances in Pulmonary Hypertension, 2017, v. 15, n. 4, p. 182, doi. 10.21693/1933-088X-15.4.182

By:

Studer, Sean M.;
Klinger, James R.

Publication type:

Article

Positioning Newer Agents: Riociguat, Selexipag, and Oral Treprostinil in the Current Landscape.

Published in:

Advances in Pulmonary Hypertension, 2017, v. 15, n. 4, p. 193, doi. 10.21693/1933-088X-15.4.193

By:

Frantz, Robert P.

Publication type:

Article

Calcium Channel Blocker Therapy: When a Drug Works, it Works. When it Doesn't, it Doesn't.

Published in:

Advances in Pulmonary Hypertension, 2017, v. 15, n. 4, p. 184, doi. 10.21693/1933-088X-15.4.184

By:

Schilz, Robert;
Rich, Stuart

Publication type:

Article